NatWest Group plc - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 158 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
NatWest Group plc ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2015$550,000
-43.6%
19,316
-28.9%
0.01%0.0%
Q2 2015$976,000
-13.1%
27,172
+40.7%
0.01%
-20.0%
Q1 2015$1,123,000
+27.3%
19,316
-7.7%
0.02%
+114.3%
Q4 2014$882,00020,9310.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2015
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders